PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • Fall in HIV among gay men could spell end for Britain's epidemic, say experts

    New data from Public Health England talks about the potential elimination of HIV, revealing the first downturn in the epidemic among gay and bisexual men since it began, thanks to a combination of frequent testing of people at high risk of infection and rapid treatment.

    22 June 2017 | The Guardian
  • Sex without fear – ​my experiment with ​the HIV-prevention drug PrEP

    When I first heard about the HIV-prevention drug PrEP – pre-exposure prophylaxis – I had mixed feelings. But I was worried that my reaction was the result of anti-gay conditioning, being brought up to think that I didn’t deserve the same rights as the rest of society, and I wanted to challenge this by taking the drug for three months to find out more.

    22 June 2017 | The Guardian
  • How doctors in Texas are trying to protect transgender patients from a persistent threat: HIV

    By offering hormone therapy, the clinic aims to earn the trust of a population that often feels alienated by mainstream medicine and persuade those at high risk of exposure to the virus to start on a drug regimen that can prevent infection.

    21 June 2017 | Los Angeles Times
  • Update on PrEP Impact trial in England

    In response to stakeholders, Public Health England (PHE) and NHS England have published an update on the PrEP Impact Trial.

    20 June 2017 | Public Health England
  • #IASYouthVoices: PrEP and Proud

    "I feel like most young men who have sex with men are invisible in the eyes of health workers." – Kyle, Johannesburg, South Africa. The #IASYouthVoices series returns this month with new stories from young people sharing how HIV affects their lives, from accessing HIV prevention to navigating treatment and care. Watch Kyle's story.

    20 June 2017 | International AIDS Society / YouTube
  • Generic PrEP approved, but not soon available

    The U.S. Food and Drug Administration has approved the first generic version of Truvada, a combination pill used for both HIV treatment and prevention, but it will not soon hit pharmacy shelves, advocates said.

    17 June 2017 | Bay Area Reporter
  • United States and Vietnam launch oral HIV pre-exposure option to reduce new infections

    Today, leaders and senior officials from the Ministry of Health (MOH), the US Embassy, PATH, local authorities, community groups, private-sector companies, and celebrities came together to officially launch pre-exposure prophylaxis (PrEP) services in Vietnam. PrEP is being offered by both private and public clinics, including those run as social enterprises by members of key populations themselves. Community-based organizations, which offer HIV testing by lay providers and HIV self-testing, are involved in screening people to see if they are eligible for PrEP and referring them to services.

    15 June 2017 | PATH
  • Viet Nam: Oral HIV pre-exposure service launched

    The Việt Nam Administration for AIDS Control in coordination with PATH has launched an oral HIV pre-exposure prophylaxis (PrEP) service in Việt Nam.

    14 June 2017 | Viet Nam News
  • US Food and Drug Administration approves a generic form of PrEP - UK comments

    Sexual health advocates hope this will widen access to PrEP, the medication that helps prevent people contracting HIV.

    14 June 2017 | Gaystar News
  • South Africa: WHO Says HIV Prevention Drug Is Essential

    A drug used to help prevent HIV has been included on the World Health Organisation's (WHO) "essential drug list", paving the way for it to be freely available in healthcare facilities around South Africa.

    13 June 2017 | AllAfrica
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.